Prognos Health

Healthcare ITSeries INew York, USprognoshealth.com

Latest round

Series I

Last raised

Apr 2023

Total raised

$63M

Investors

14

About Prognos Health

Founded in 2010, Prognos Health Inc. operates from its headquarters in New York, US. The company focuses on integrating laboratory and health records to provide actionable insights for pharmaceutical companies.Prognos Health specializes in providing clinical and genomic laboratory data solutions tailored for the life sciences industry. Their core offerings include comprehensive datasets that integrate lab and health records, serving over 325 million patients. These products are designed to empower pharmaceutical companies by delivering actionable insights derived from harmonized clinical data, thus facilitating the identification of appropriate healthcare providers (HCPs) and optimizing treatment patterns. Prognos Health’s products are utilized across various therapeutic areas, enabling clients to effectively educate HCPs on brand-eligible treatments before critical treatment decisions are made.Prognos Health generates revenue through a subscription-based model that grants clients access to its extensive data offerings. Clients, which include pharmaceutical companies and healthcare organizations, engage in direct partnerships to utilize Prognos’ lab data for commercial analytics and marketing strategies. Standard transactions often involve tailored service agreements that allow clients to leverage Prognos’ real-world data capabilities, streamlining their analytical processes. These partnerships facilitate rapid access to high-fidelity laboratory data, which enhances the clients' decision-making capabilities without the lengthy delays typically associated with data ingestion.29 mn in April 2023, Prognos Health Inc. plans to utilize these funds to accelerate business growth and expand its platform. The company is focusing on developing new products tailored to evolving market needs, with specific plans to enhance its offerings in oncology and rare diseases. Additionally, Prognos aims to expand into new geographic regions, targeting both domestic and international markets by the end of 2024.

Who invested in Prognos Health

14 investors across 5 rounds

See all investors in Prognos Health

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series I

    Apr 10, 2023

    Amount

    $23M

    Investors

    Locked

  2. Series C

    Nov 3, 2017

    Amount

    $17M

    Investors

    Locked

  3. Series B

    Jun 17, 2013

    Amount

    $15M

    Investors

    Locked

  4. Series A

    Nov 17, 2011

    Amount

    $7M

    Investors

    Locked

  5. Seed

    Dec 12, 2010

    Amount

    $0.7M

    Investors

    Locked

Questions about Prognos Health

Who invested in Prognos Health?

Prognos Health has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Prognos Health raised?

Prognos Health has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Prognos Health last raise money?

Prognos Health's most recent round on record is a Series I, in Apr 2023.

What does Prognos Health do?

Founded in 2010, Prognos Health Inc.

Where is Prognos Health headquartered?

Prognos Health is headquartered in New York, US.

Which VCs invest in companies like Prognos Health?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Prognos Health's stage. Their profiles are linked below.

Raising like Prognos Health? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.